- Home
- TIL vs WIA Comparison
TIL vs WIA Comparison
Compare TIL & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- WIA
- Stock Information
- Founded
- TIL 2018
- WIA 2003
- Country
- TIL United States
- WIA United States
- Employees
- TIL N/A
- WIA N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- TIL Health Care
- WIA Finance
- Exchange
- TIL Nasdaq
- WIA Nasdaq
- Market Cap
- TIL 230.1M
- WIA 192.9M
- IPO Year
- TIL 2021
- WIA N/A
- Fundamental
- Price
- TIL $23.14
- WIA $8.40
- Analyst Decision
- TIL Buy
- WIA
- Analyst Count
- TIL 5
- WIA 0
- Target Price
- TIL $119.00
- WIA N/A
- AVG Volume (30 Days)
- TIL 387.8K
- WIA 39.2K
- Earning Date
- TIL 08-12-2025
- WIA 01-01-0001
- Dividend Yield
- TIL N/A
- WIA 12.29%
- EPS Growth
- TIL N/A
- WIA N/A
- EPS
- TIL N/A
- WIA N/A
- Revenue
- TIL N/A
- WIA N/A
- Revenue This Year
- TIL N/A
- WIA N/A
- Revenue Next Year
- TIL N/A
- WIA N/A
- P/E Ratio
- TIL N/A
- WIA N/A
- Revenue Growth
- TIL N/A
- WIA N/A
- 52 Week Low
- TIL $9.62
- WIA $7.56
- 52 Week High
- TIL $92.00
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- TIL 43.15
- WIA 69.19
- Support Level
- TIL $21.29
- WIA $8.25
- Resistance Level
- TIL $31.67
- WIA $8.42
- Average True Range (ATR)
- TIL 3.95
- WIA 0.07
- MACD
- TIL -1.71
- WIA 0.02
- Stochastic Oscillator
- TIL 8.60
- WIA 93.33
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.